[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

The World Market for Pituitary (Anterior) or Similar Hormones and Derivatives: A 2024 Global Trade Perspective

May 2023 | 58 pages | ID: W1D9766C000EN
ICON Group International

US$ 461.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report was created for strategic planners, international executives, and import/export managers who are concerned with the market for pituitary (anterior) or similar hormones and derivatives. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact. Professor Philip M. Parker, the Chair Professor of Management Science at INSEAD, has developed a methodology, based on macroeconomic and trade models, to estimate the market for pituitary (anterior) or similar hormones and derivatives for those countries serving the world market via exports or supplying from various countries via imports. He does so for the current year based on a variety of key historical indicators and econometric models.

'Pituitary (anterior) or similar hormones and derivatives' as a category is defined in this report following the definition given by the United Nations Statistics Division Classification Registry using the Standard International Trade Classification, Revision 3 (SITC, Rev. 3). The SITC code that defines 'pituitary (anterior) or similar hormones and derivatives' is 54152.
1 METHODOLOGY

1.1 OUR APPROACH

2 THE WORLD MARKET

2.1 EXPORTS
  2.1.1 THE WORLD MARKET: PITUITARY (ANTERIOR) OR SIMILAR HORMONES AND DERIVATIVES EXPORT SUPPLIES IN 2024
2.2 IMPORTS
  2.2.1 THE WORLD MARKET: IMPORTED PITUITARY (ANTERIOR) OR SIMILAR HORMONES AND DERIVATIVES IN 2024

3 EXPORTS

3.1 ASIA: EXPORT SUPPLIES OF PITUITARY (ANTERIOR) OR SIMILAR HORMONES AND DERIVATIVES IN 2024
  3.1.1 EXECUTIVE SUMMARY
  3.1.2 CHINA
  3.1.3 INDIA
  3.1.4 SOUTH KOREA
3.2 EUROPE: EXPORT SUPPLIES OF PITUITARY (ANTERIOR) OR SIMILAR HORMONES AND DERIVATIVES IN 2024
  3.2.1 EXECUTIVE SUMMARY
  3.2.2 AUSTRIA
  3.2.3 BELGIUM
  3.2.4 FRANCE
  3.2.5 GERMANY
  3.2.6 HUNGARY
  3.2.7 IRELAND
  3.2.8 ITALY
  3.2.9 SPAIN
  3.2.10 SWEDEN
  3.2.11 SWITZERLAND
  3.2.12 THE UNITED KINGDOM
3.3 LATIN AMERICA: EXPORT SUPPLIES OF PITUITARY (ANTERIOR) OR SIMILAR HORMONES AND DERIVATIVES IN 2024
  3.3.1 EXECUTIVE SUMMARY
  3.3.2 ARGENTINA
3.4 NORTH AMERICA & THE CARIBBEAN: EXPORT SUPPLIES OF PITUITARY (ANTERIOR) OR SIMILAR HORMONES AND DERIVATIVES IN 2024
  3.4.1 EXECUTIVE SUMMARY
  3.4.2 CANADA
  3.4.3 THE UNITED STATES
3.5 OCEANIA: EXPORT SUPPLIES OF PITUITARY (ANTERIOR) OR SIMILAR HORMONES AND DERIVATIVES IN 2024
  3.5.1 EXECUTIVE SUMMARY
  3.5.2 AUSTRALIA
3.6 THE MIDDLE EAST: EXPORT SUPPLIES OF PITUITARY (ANTERIOR) OR SIMILAR HORMONES AND DERIVATIVES IN 2024
  3.6.1 EXECUTIVE SUMMARY
  3.6.2 ISRAEL

4 IMPORTS

4.1 AFRICA: PITUITARY (ANTERIOR) OR SIMILAR HORMONES AND DERIVATIVES IMPORTS IN 2024
  4.1.1 EXECUTIVE SUMMARY
  4.1.2 ALGERIA
  4.1.3 EGYPT
  4.1.4 NIGERIA
4.2 ASIA: PITUITARY (ANTERIOR) OR SIMILAR HORMONES AND DERIVATIVES IMPORTS IN 2024
  4.2.1 EXECUTIVE SUMMARY
  4.2.2 INDIA
  4.2.3 JAPAN
  4.2.4 SOUTH KOREA
4.3 EUROPE: PITUITARY (ANTERIOR) OR SIMILAR HORMONES AND DERIVATIVES IMPORTS IN 2024
  4.3.1 EXECUTIVE SUMMARY
  4.3.2 AUSTRIA
  4.3.3 BELGIUM
  4.3.4 FRANCE
  4.3.5 GERMANY
  4.3.6 IRELAND
  4.3.7 SPAIN
  4.3.8 SWEDEN
  4.3.9 SWITZERLAND
  4.3.10 THE UNITED KINGDOM
  4.3.11 UKRAINE
4.4 LATIN AMERICA: PITUITARY (ANTERIOR) OR SIMILAR HORMONES AND DERIVATIVES IMPORTS IN 2024
  4.4.1 EXECUTIVE SUMMARY
  4.4.2 MEXICO
4.5 NORTH AMERICA & THE CARIBBEAN: PITUITARY (ANTERIOR) OR SIMILAR HORMONES AND DERIVATIVES IMPORTS IN 2024
  4.5.1 EXECUTIVE SUMMARY
  4.5.2 CANADA
  4.5.3 THE UNITED STATES
4.6 OCEANIA: PITUITARY (ANTERIOR) OR SIMILAR HORMONES AND DERIVATIVES IMPORTS IN 2024
  4.6.1 EXECUTIVE SUMMARY
  4.6.2 AUSTRALIA

5 DISCLAIMERS, WARRANTIES, AND USER AGREEMENT PROVISIONS

5.1 DISCLAIMERS & SAFE HARBOR
5.2 ICON GROUP INTERNATIONAL, INC. USER AGREEMENT PROVISIONS


More Publications